News
QKS Group announced today that it has named Zimperium as a 2025 technology leader in the SPARK Matrixtm: In-App Protection, 2025. Ayush Patidar, Analyst at QKS Group, states, "Zimperium MAPS delivers ...
The Swiss pharma has reached a deal to buy Spark in an all-cash transaction at a price of $114.50 per share, a premium of 122% to the US company's closing price on Friday evening.
As previously reported, Wolfe Research analyst Andy Chen upgraded Intellia Therapeutics (NTLA) to Outperform from Peer Perform with a $21 price target With enterprise value now seen at about zero ...
Guggenheim initiated coverage of Unicycive Therapeutics (UNCY) with a Buy rating and $6 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter ...
Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease. It looked likely that the FDA would approve the US ...
WALTHAM, Mass., April 21, 2025 /PRNewswire/ -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE) ("Aerovate") today announced that its stockholders have approved the ...
DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a ...
Founded in 2004 and headquartered in Lexington, MA, Aldeyra Therapeutics is advancing a pipeline of therapies targeting immune-mediated diseases by modulating reactive aldehyde species (RASP), an ...
HEMLIBRA has strong market potential due to its unique, subcutaneous prophylactic treatment for Hemophilia A, including patients with and without factor VIII inhibitors. With increasing global ...
The country music star and the actress jointly posted the photo on Instagram on April 20 to wish fans a "Happy Easter" Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been ...
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results